Data

National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD) collection

Australian Institute of Health and Welfare
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=https://www.aihw.gov.au/about-our-data/our-data-collections#N&rft.title=National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD) collection&rft.publisher=Australian Institute of Health and Welfare&rft.description=The main purpose of the NOPSAD collection is to aggregate standardised jurisdictional data on the number of clients accessing pharmacotherapy for the treatment of opioid dependence, the number of prescribers participating in the delivery of pharmacotherapy treatment, and quantitative information about the prescribing sector. As such, national information on pharmacotherapy, on a snapshot day each year, can be reported.The collection covers the provision of opioid pharmacotherapy treatment, the practitioners who prescribe the treatment, the dosing sites who dispense the pharmacotherapy drugs, and the clients receiving the opioid pharmacotherapy treatment. The following pharmacotherapies are currently recommended for the treatment of opioid dependency: Methadone hydrochloride Methadone Syrup®, Biodone Forte ® Buprenorphine Subutex® Buprenorphine/ Naloxone Suboxone®, buprenorphine as long acting injections (Buvidal® and Sublocade®).Methodology: Official&rft.creator=Anonymous&rft.date=2025&rft.coverage=National and State&rft_rights=Publications, Summary tables published in electronic form, Statistics, Client specified tables on request which may be subject to data provider approval (charges apply), Unit records are not available&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Licence & Rights:

view details

Publications, Summary tables published in electronic form, Statistics, Client specified tables on request which may be subject to data provider approval (charges apply), Unit records are not available

Access:

Other

Full description

The main purpose of the NOPSAD collection is to aggregate standardised jurisdictional data on the number of clients accessing pharmacotherapy for the treatment of opioid dependence, the number of prescribers participating in the delivery of pharmacotherapy treatment, and quantitative information about the prescribing sector. As such, national information on pharmacotherapy, on a snapshot day each year, can be reported.

The collection covers the provision of opioid pharmacotherapy treatment, the practitioners who prescribe the treatment, the dosing sites who dispense the pharmacotherapy drugs, and the clients receiving the opioid pharmacotherapy treatment. The following pharmacotherapies are currently recommended for the treatment of opioid dependency: Methadone hydrochloride Methadone Syrup®, Biodone Forte ® Buprenorphine Subutex® Buprenorphine/ Naloxone Suboxone®, buprenorphine as long acting injections (Buvidal® and Sublocade®).

Notes

Variables to support reporting and linkage: Age (Date of birth); Sex/gender Indigenous status; SA2

Lineage

Methodology: Official

Data time period: to

Spatial Coverage And Location

text: National and State

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

ACN 633 798 857